1. In this study an acute anti-hypertensive effect of three anti-oxidant agents (vitamin C, thiopronine and glutathione) in hypertensive subjects and in both hypertensive and non-hypertensive diabetic patients is reported.
INTRODUCTION
Thirty per cent of the adult population may have arterial hypertension [ 11, and an estimated 30-60% of diabetic patients have associated hypertension 121.
Endothelial cells play a major role in the relaxation of arteries [3]. The factor released by the endothelium that causes vascular relaxation is called endothelium-derived relaxing factor, and nitric oxide is believed to be one such relaxing factor [4] . The half-life of nitric oxide is a few seconds only, since it is rapidly degraded by the oxygenderived free radical superoxide anion [3] .
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An imbalance of this system has been hypothesized to play a role in the development of arterial hypertension [3]. In this respect, the demonstration that the aortic smooth muscle of spontaneously hypertensive rats exhibits an increased reactivity to oxygen-derived free radicals is of particular interest [5] .
The aim of this study was to attempt to evaluate the eventual role of free radicals in human hypertension. For this purpose, we evaluated the effect of the acute administration of three well-known anti-oxidant agents, namely vitamin C [6], thiopronine [7] and glutathione [8], on blood pressure. Our study was performed in diabetic and non-diabetic hypertensive patients, and, as a comparison, in a group of age-and sex-matched healthy control subjects and non-hypertensive diabetic subjects.
MATERIALS AND METHODS

Subjects
Twenty patients (12 males and eight females, age 28-45 years) with mild to moderate essential hypertension [9] entered the study if their supine diastolic blood pressure (DBP) was within the range 95-115 mmHg on at least 3 days while they were hospitalized and remained in balance while receiving a constant sodium (100 mmol/ day) and potassium (40 mmol/day) diet. Ten of them (five males and five females, age 28-38 years) were insulindependent diabetic patients. Their insulin regimen ranged between 20 and 44 units/day. The patients were either untreated or had their anti-hypertensive medication withheld for at least 2 weeks before the study. The patients had no clinical or laboratory evidence of cardiac or renal diseases, none showed macro-or micro-albuminuria and none was taking any long-term medication. Ten normal healthy subjects (six males and four females, age 30-45 years) and ten non-hypertensive insulin-dependent dia-betic patients (age 25-37 years, insulin regimen 22-40 units/day) served as control groups.
This experiment was approved by the review board for human experiments of our institution, and all subjects gave their informed consent to participate in the study after a detailed explanation of its experimental nature had been given.
Study design
Seven studies were performed in each subject, in randomized order and on different days, in a double-blind regimen. All subjects were tested in the post-absorptive state at an ambient temperature of 22°C. Evaluation of blood pressure and heart rate was performed at 15 rnin intervals during a 2 h basal period and at 10 rnin intervals over a 1 h period after the intravenous bolus administration of either 10 ml of 0.9% (w/v) NaCl or one of the active anti-oxidant agents vitamin C (Vita Farmaceutici, Milano, Italy), thiopronine (an acetylcysteine analogue; Proter, Milano, Italy) or glutathione (Boehringer Mannheim, Mannheim, Germany) at dose of 6 and 12 mmol, dissolved in 10 ml of 0.9% (w/v) NaC1. The dose of 6 mmol of drug was selected because 6 mmol of vitamin C equals 1 g, a dose frequently used in therapeutics.
Blood pressure and heart rate were measured with the subjects in the supine position. The mean of the measurements in the pre-infusion period were considered as the basal values. The mean of two measurements was recorded at each point of the post-infusional period of the study. Blood pressure and heart rate were measured with an ambulatory monitor, an automatic process that produces a readout on paper and thus eliminates observer bias. The same arm was used for the readings every time.
In diabetic patients the fasting plasma glucose concentration was measured at the beginning of each experiment.
Statistical analysis
Analyses of statistical significance was carried out by analysis of variance. A probability value of less than 0.05 was considered to be significant.
RESULTS
Systolic blood pressure (SBP) and DBP were not significantly different between diabetic and non-diabetic hypertensive patients in the basal state, as well as at the beginning of each experiment (Fig. 1) . The administration of 6 mmol of each anti-oxidant produced a rapid and significant decrease in SBP and DBP in both groups of hypertensive patients ( P < 0.01 versus basal values) and in non-hypertensive diabetic patients ( P < 0.01 versus basal values), but had no significant effect in normal healthy subjects (Fig. 1 ) .
The anti-hypertensive effect was present by 10 min. At 30 rnin blood pressure values returned to the basal range ( Fig. 1) (data not shown). The effect was modest with vitamin C, and glutathione exhibited the greatest effect (Fig. 1) .
A dose of 12 mmol of each anti-oxidant was administered in a further series of experiments. At this dose thiopronine and glutathione produced a significant decrease in the blood pressure values in normal subjects as well, whereas vitamin C was uneffective in these subjects (Fig.  1) . In the three other groups, the anti-oxidants showed a dose-dependent effect (Fig. 1) .
The acute anti-hypertensive effect of the anti-oxidant compounds was stronger in the non-diabetic than in the diabetic hypertensive patients ( Fig. 1 ; P< 0.05 between the groups). At the same time, both the percentage effect and the absolute effect of these drugs on blood pressure was greater in non-hypertensive than in hypertensive diabetic patients ( P < 0.05). The mean fasting plasma glucose concentration was more elevated in hypertensive than in non-hypertensive diabetic patients (8.5 f 0.34 versus 7.4 k 0.44 mmol/l, mean -t-SEM; P< 0.01).
During hypotensive periods there were no significant changes in heart rate compared with basal values (data not shown).
DISCUSSION
In this study a significant anti-hypertensive effect of three anti-oxidant agents injected intravenously was demonstrated. Since they all produced a similar effect, it seems obvious to us that this effect may be related precisely to their anti-oxidant action.
The equimolar administration of each substance produced a different effect, glutathione being the most effective. These different effects may be hypothesized to be linked to the specific mechanism by which each substance acts as a anti-oxidant. Vitamin C contributes to the protection afforded by vitamin E [6] , thiopronine is a substrate for glutathione synthesis [7] and has a relative direct anti-oxidant capacity [ 103, and glutathione acts directly on free-radical species [S] .
Many reports suggest that anti-oxidant deficiency plays a role in the aetiology of hypertension [ll-131. A minor anti-oxidant property has been reported [ 141 in the plasma of diabetic patients. Moreover, in both diabetic and hypertensive patients an abnormal endotheliumdependent vascular relaxation has been reported [15, 16] . In this regard, hypertensive patients and both hypertensive and non-hypertensive diabetic patients seem to be similar.
An impaired relaxation of blood vessels from both spontaneously diabetic rats [ 171 and hypertensive rats [3] , owing to altered production of an endothelium-dependent relaxant agent, has been demonstrated recently. Hence, the anti-oxidants might simply restore this altered production: one may hypothesize that this condition may produce a relative rise in the superoxide anion effects, which might be considered as one of the factors facilitating the development of an arterial functional spasm. The reasons for the different response between diabetic and non-diabetic hypertensive subjects and for the effect of the anti-oxidants in diabetic patients but not in normal subjects at the lower dose tested remains unclear. Increased superoxide anion generation has been reported in serum from diabetic patients [18] . A role for a prevalence of free-radical generation in diabetic patients might be hypothesized, glycosylated proteins and glucose, themselves being important sources of free radicals [19, 201. On the other hand, the possibility that oxygen-derived free radicals may specifically abolish endotheliumdependent relaxation in the aorta of diabetic [21] and hypertensive [5] rats, and the evidence that the antioxidants ameliorate the abnormal arterial vasomotion in diabetes [22] , support the hypothesis that a sensitivity to free radicals might exist in diabetes and in hypertension.
The anti-hypertensive effect of the drugs was more evident in non-hypertensive than in hypertensive diabetic patients. An elevated plasma glucose concentration may impair endothelium-dependent relaxation in the rabbit [23] . Hence the difference in plasma glucose concentration between the two groups of diabetic patients might account for the different effects of the drugs.
A direct vasodilatatory action of the three compounds may be not excluded, as the vasorelaxant property of the endothelium-derived relaxing factor has been demonstrated to more closely resemble S-nitrosocysteine and Snitrosoglutathione than nitric oxide [24] . The dose-dependent effect seen in normal subjects seems to suggest that these compounds might have a direct vasodilatatory effect. This study shows, for the first time, that some anti-oxidant agents may produce a reduction in blood pressure in hypertensive and non-hypertensive diabetic patients and in hypertensive patients, whereas this effect seems to be dose-dependent in normal subjects. These data suggest that anti-oxidants might have a dilatatory effect and that an imbalance of the nitric oxide-free radical interaction might facilitate the development of hypertension in humans.
